Regulation of Cell-mediated Immunity During Reinfection with Influenza Virus PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Regulation of Cell-mediated Immunity During Reinfection with Influenza Virus PDF full book. Access full book title Regulation of Cell-mediated Immunity During Reinfection with Influenza Virus by Melinda Annetta Beck. Download full books in PDF and EPUB format.
Author: Melinda Annetta Beck
Publisher:
ISBN:
Category : Cellular immunity
Languages : en
Pages : 416
Get Book Here
Book Description
Author: Melinda Annetta Beck
Publisher:
ISBN:
Category : Cellular immunity
Languages : en
Pages : 416
Get Book Here
Book Description
Author: François Coulombe
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
"Influenza virus infection causes a complex respiratory disease inflicting a persistent threat to human health worldwide and presenting challenges to clinicians who are left with no available therapeutic interventions. The broad complexity of the disease is the consequence of host-pathogen interactions, which may result in severe influenza- associated illness and death. Severity of influenza infections correlates with the ability of the virus to reach and replicate within the lower respiratory tract, where it encounters alveolar macrophages. These cells reside in close contact with the respiratory epithelium of the lower airways and are the first immune cells to make contact with the influenza virus. Despite evidence showing their critical role in anti-viral immunity and in the maintenance of pulmonary homeostasis, the regulatory mechanisms that drive macrophage function during severe influenza virus infection are poorly defined.The first part of the work presented herein focuses on the function of host-derived lipid mediators, known as eicosanoids, in the regulation of macrophage function during influenza virus infection. Using mice deficient in various components of the eicosanoid biosynthesis pathways, we first established that influenza virus specifically hijacks the prostaglandin E2 pathway to subvert macrophage function and suppress both innate and adaptive immune responses. We identified two distinct pathways through which prostaglandin E2 paralyzed macrophage anti-viral immunity: type I interferon and apoptosis. The impairment of these two pathways severely hinders the innate immune response as type I interferon directly counteracts viral replication, while apoptosis blocks the cellular machinery crucial for viral amplification/dissemination. In addition, we found that prostaglandin E2 suppresses adaptive immunity to influenza virus infection. Importantly, prostaglandin E2-deficient mice were more protected against influenza and pharmacological inhibition of prostaglandin E2 recapitulated this protective effect against the virus.Next, we demonstrated that mice deficient in the 5-lipoxygenase pathway showed remarkable protection against influenza infection. This protection was associated with a concomitant lack of lipoxin A4 up-regulation in infected mice, as well as early expansion of granulocyte macrophage-colony stimulating factor (GM-CSF)-secreting alveolar macrophages in the airways. GM-CSF has a well-established protective role against pulmonary viral infection and specific inhibition of GM-CSF in 5-lipoxygenase deficient mice abrogated their protection against influenza.The second part of this thesis focuses on the consequences of macrophage death modality during the course of influenza virus infection. While host-induced apoptosis of infected cells is a mechanism to restrict viral replication, influenza virus paradoxically has been shown to induce early apoptosis in immune cells, especially in monocytes/macrophages, via its PB1-F2 accessory protein. Here, we demonstrate that the host NLRX1 receptor can effectively interact with the influenza virus pro-apoptotic protein PB1-F2 in macrophage mitochondria, thereby preventing PB1-F2-induced apoptosis and leading to increased type I interferon production by macrophages. The interaction between host NLRX1 and viral PB1-F2 in macrophages was furthermore critical for the control of influenza virus replication.Taken together, our results suggest that eicosanoids and apoptosis act in concert as critical regulators of macrophage-mediated immunity against severe influenza virus infection. We propose that macrophages act as the cellular switch initiating the pulmonary anti-viral responses by monitoring the balance between virus-triggered or host-triggered production of eicosanoids and induction of apoptosis. We further envision that immunotherapies targeting specific eicosanoids offer promising avenues for treatment of influenza and potentially other viral infections." --
Author: Kenneth Murphy
Publisher: Garland Science
ISBN: 9780815344575
Category : Medical
Languages : en
Pages :
Get Book Here
Book Description
The Janeway's Immunobiology CD-ROM, Immunobiology Interactive, is included with each book, and can be purchased separately. It contains animations and videos with voiceover narration, as well as the figures from the text for presentation purposes.
Author: Janina Megan Jansen
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Author: David S. Hui
Publisher: European Respiratory Society
ISBN: 1849840709
Category : Medical
Languages : en
Pages : 148
Get Book Here
Book Description
Viral respiratory tract infections are important and common causes of morbidity and mortality worldwide. In the past two decades, several novel viral respiratory infections have emerged with epidemic potential that threaten global health security. This Monograph aims to provide an up-to-date and comprehensive overview of severe acute respiratory syndrome, Middle East respiratory syndrome and other viral respiratory infections, including seasonal influenza, avian influenza, respiratory syncytial virus and human rhinovirus, through six chapters written by authoritative experts from around the globe.
Author: Hiroshi Kiyono
Publisher: Elsevier
ISBN: 0080537057
Category : Medical
Languages : en
Pages : 501
Get Book Here
Book Description
This comprehensive, authoritative treatise covers all aspects of mucosal vaccines including their development, mechanisms of action, molecular/cellular aspects, and practical applications. The contributing authors and editors of this one-of-a-kind book are very well known in their respective fields. Mucosal Vaccines is organized in a unique format in which basic, clinical, and practical aspects of the mucosal immune system for vaccine development are described and discussed. This project is endorsed by the Society for Mucosal Immunology. Provides the latest views on mucosal vaccines Applies basic principles to the development of new vaccines Links basic, clinical, and practical aspects of mucosal vaccines to different infectious diseases Unique and user-friendly organization
Author: Morris Pollard
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 322
Get Book Here
Book Description
Author: Elizabeth Emlika Waffarn
Publisher:
ISBN: 9781321364187
Category :
Languages : en
Pages :
Get Book Here
Book Description
Multiple B lymphocyte subsets contribute to immune responses to pathogens. Among these, B-1 cells are a small subset of innate-like B cells whose development, phenotype, tissue distribution, and functions are distinct from those of conventional B-2 cells, and whose responses are crucial to protection against mucosal bacterial and viral pathogens. B-1 cells contribute to protective responses even before infection, by secreting natural antibody, a polyspecific repertoire of mostly IgM antibodies produced constitutively in the absence of foreign antigens. In response to influenza virus infection, B-1 cells actively respond by accumulating locally in draining mediastinal lymph nodes (MedLN), where they differentiate to secrete both virus-binding and non virus-binding IgM. Multiple details from those earlier studies suggest that the regulation of B-1a cell responses differs from that of conventional B-2 cells and that infection-induced but antigen-independent mechanisms contribute to B-1a cell activation and function. This dissertation explores the hypothesis that B-1 cells are regulated by the quality and magnitude of local infection-induced innate immune signals, including type I interferon (IFNs) and IL-1, critical mediators of anti-viral responses and pro-inflammatory signaling. Previous studies of IL1R-/- mice showed that IL-1 signaling was required for maximal secretion of IgM and IgA after influenza infection. Because B-1 cells contribute at least half of influenza-induced IgM, we investigated the effects of IL-1 on B-1 cell redistribution and activation for IgM secretion. The studies outlined in the Second Chapter revealed that direct IL-1 stimulation did not contribute to the redistribution of B-1 cells to the lymph nodes, as it was neither directly chemotactic for B-1 cells, did not mobilize B-1 cells in vivo, nor altered the ability of B-1 cells to respond to the lymph node homing chemokines CXCL12 and CXCL13 in vitro. Instead, we found that IL-1 treatment alone modestly induced their IgM secretion in vitro. Using chimeric mice in which only B-1 cells lacked the IL-1R and which are distinguishable from B-2 cells based on Ig-allotypic differences, we investigated the ability of B-1 cells to respond to influenza virus infection. The data showed that these signals were required for maximum induction not only of CD5- B-1 cells, but also of the mostly B-2 cell-derived plasma blasts. Consistent with these findings we found IgM production both by B-1 and B-2 cells reduced. To begin to determine the mechanism by which B-1 cell IL-1 stimulation causes B-2 cell differentiation, we found that IL-1 stimulation selectively induced GM-CSF stimulation by B-1 cells. Furthermore, supernatants of IL-1-stimulated B-1 cells were able to induce IgM secretion by B-2 cells in vitro. Together, these findings suggest that activated B-1 cells play a regulatory role within lymph nodes by guiding conventional B-2 cell responses. In the Third Chapter, we took a genome-wide gene expression array approach to conduct an unbiased analysis of B-1a cell populations in the peritoneal and pleural cavity and the spleen, before and at two time points after infection. The goal was to identify all signals that affect B-1a cells following influenza infection in vivo and to identify a likely source from which lymph node B-1 cells were recruited. Somewhat surprisingly, the results revealed strong gene expression differences present before infection between B-1 cells from different tissues. Influenza virus infection further altered gene expression from all three sites, but the strongest changes occurred in pleural cavity B-1a cells within 2 days of infection, indicating that rapidly induced, locally elaborated infection signals impact B-1a cells. Based on the affected genes, type I IFN was identified as a strong early innate factor providing site-specific signaling to B-1a cells. These results suggest that B-1a cells receive site-specific signals even prior to infection and that infection-induced local signals strongly affect pleural cavity B-1a cells, likely shaping their antiviral response. The Fourth Chapter investigates the tissue origins of B-1a cells accumulating at the site of influenza infection and the role of type I IFN in their migration and differentiation. Labeled B-1a cells preferentially redistributed from pleural cavity sites to the draining MedLN after influenza infection, consistent with the results of our microarray analyses. However, in mice in which only B cells, or only B-1 cells lacked IFNR-expression, this enhanced accumulation was absent suggesting a role for type I IFN signaling B-1 cell redistribution. An in vitro vascular mimetic chamber model was used to evaluate the adherence of B-1 cells to a substrate consisting of ICAM-1 and CXCL13. Strikingly, type I IFN treatment or in vivo influenza infection stimulated B-1 cells to arrest on the substrate. Antibody-blocking studies showed that this was due to the increased integrin-mediated binding to ICAM-1. In vivo competition experiments designed to measure the ability of B-1 cells, from wildtype and CD11b or CD11a integrin-deficient mice, to accumulate in the MedLN in response to influenza infection after transfer into the pleural cavity of recipient mice, demonstrated the importance of CD11b in the B-1 cell redistribution process. Further studies suggested that type I IFN acts to enhance CD11b-mediated lymph node accumulation by activating the conformation state of CD11b. These studies identify a novel axis of type I IFN mediated integrin activation for rapid regulation of innate lymphocyte redirection. Together, these studies provide two examples of innate-signaling mediated regulation of B-1 cell responses during influenza infection. The results indicate that B-1 cells in the body cavities are optimally positioned to rapidly respond to an infection and that their characteristic expression of CD11b aids in rapid migration and accumulation in regional lymphoid tissues. Finally, the results of this study also suggest that B-1a cells broadly regulate the adaptive antiviral response by providing non-redundant signals to conventional B-2 cells for maximal induction of virus-specific antibody responses.
Author: Nai Ki Mak
Publisher:
ISBN:
Category : Cellular immunity
Languages : en
Pages : 456
Get Book Here
Book Description
Author: R. Ahmed
Publisher: Wiley-Blackwell
ISBN:
Category : Medical
Languages : en
Pages : 754
Get Book Here
Book Description
Persistent Viral Infections Edited by Rafi Ahmed Emory Vaccine Center, Atlanta, USA and Irvin S. Y. Chen UCLA School of Medicine, Los Angeles, USA During the past decade much of our attention has focused on diseases associated with viral persistence. Major breakthroughs in immunology, and the advent of molecular approaches to study pathogenesis have increased our understanding of the complex virus-host interactions that occur during viral persistence. Persistent Viral Infections focuses on: * The pathogenesis and immunology of chronic infections * Animal models that provide, or have the potential to provide, major insights This volume will be essential reading for virologists, immunologists, oncologists and neurologists.
